Helen of Troy Limited (NASDAQ:HELE) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Helen of Troy Limited (NASDAQ:HELE) have earned an average recommendation of “Moderate Buy” from the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $24.00.

Several analysts have recently commented on the stock. Zacks Research upgraded shares of Helen of Troy from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. UBS Group increased their target price on shares of Helen of Troy from $16.00 to $25.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Canaccord Genuity Group increased their target price on shares of Helen of Troy from $18.00 to $23.00 and gave the company a “hold” rating in a report on Friday, April 24th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Helen of Troy in a report on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Helen of Troy from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd.

Institutional Trading of Helen of Troy

Institutional investors and hedge funds have recently made changes to their positions in the company. Envestnet Asset Management Inc. raised its holdings in shares of Helen of Troy by 42.4% in the third quarter. Envestnet Asset Management Inc. now owns 195,657 shares of the company’s stock valued at $4,931,000 after purchasing an additional 58,214 shares during the last quarter. RWWM Inc. increased its holdings in Helen of Troy by 167.1% during the third quarter. RWWM Inc. now owns 515,176 shares of the company’s stock worth $12,982,000 after buying an additional 322,315 shares during the last quarter. Counterpoint Mutual Funds LLC increased its holdings in Helen of Troy by 882.6% during the third quarter. Counterpoint Mutual Funds LLC now owns 125,416 shares of the company’s stock worth $3,160,000 after buying an additional 112,652 shares during the last quarter. Invenomic Capital Management LP increased its holdings in Helen of Troy by 68.8% during the third quarter. Invenomic Capital Management LP now owns 554,985 shares of the company’s stock worth $13,986,000 after buying an additional 226,263 shares during the last quarter. Finally, Moloney Securities Asset Management LLC purchased a new stake in Helen of Troy during the third quarter worth about $1,120,000.

Helen of Troy News Roundup

Here are the key news stories impacting Helen of Troy this week:

• Neutral Sentiment: Multiple entertainment and opinion pieces mention “Helen of Troy” in connection with Lupita Nyong’o’s casting in The Odyssey, which may be drawing extra attention to HELE but does not reflect a change in the company’s fundamentals. Lupita Nyong’o Responds to Backlash Over Helen of Troy Casting in The Odyssey
• Neutral Sentiment: The articles also discuss backlash, race, and casting debates around the film, which may increase chatter around the name “Helen of Troy” but has no direct operational impact on Helen of Troy Limited. ‘The Odyssey’ Star Lupita Nyong’o Responds to Racist Casting Backlash: ‘This Is a Mythological Story’
• Negative Sentiment: If investors confuse the entertainment headlines with the consumer products company, that could add noise and volatility without any real business catalyst for HELE. Lupita Nyong’o Is ‘Honored’ to Be Your Helen of Troy

Helen of Troy Stock Performance

HELE opened at $24.79 on Friday. The company has a current ratio of 1.71, a quick ratio of 0.81 and a debt-to-equity ratio of 0.95. The company’s fifty day moving average price is $19.14 and its two-hundred day moving average price is $19.03. Helen of Troy has a 1-year low of $13.85 and a 1-year high of $33.73. The company has a market cap of $576.62 million, a price-to-earnings ratio of -0.63 and a beta of 1.29.

Helen of Troy (NASDAQ:HELE) last released its quarterly earnings data on Thursday, April 23rd. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.09. The firm had revenue of $470.03 million for the quarter, compared to the consensus estimate of $450.38 million. Helen of Troy had a negative net margin of 50.33% and a positive return on equity of 7.00%. The business’s revenue was down 3.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.33 earnings per share. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. On average, analysts expect that Helen of Troy will post 2.81 EPS for the current fiscal year.

Helen of Troy Company Profile

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.